讨论
美队32018-07-10 06:36
美队32018-07-10 06:36
极限玩家2018-07-06 23:16
$Aquinox制药(AQXP)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-08-13 AccNo: 0001144204-19-039617 Size: 110 KB 网页链接
$Aquinox制药(AQXP)$ 8-K - Current report Filed: 2019-08-12 AccNo: 0001193125-19-218513 Size: 1 MBItem 1.01: Entry into a Material Definitive AgreementItem 2.01: Completion of Acquisition or Disposition of AssetsItem 2.03: Creation of a Direct Financial Obligation or an Obliga...
$Aquinox制药(AQXP)$ 内部交易: 2019-08-07,Director,BAKER BROS. ADVISORS LP ,买入,289725普通股, $3.05
$Aquinox制药(AQXP)$ 内部交易: 2019-08-06,Director,BAKER BROS. ADVISORS LP ,买入,81800普通股, $2.85
$Aquinox制药(AQXP)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-08-07 AccNo: 0001144204-19-038249 Size: 141 KB 网页链接
$Aquinox制药(AQXP)$ 8-K - Current report Filed: 2019-08-06 AccNo: 0001193125-19-213526 Size: 4 MBItem 1.01: Entry into a Material Definitive AgreementItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Ar...
$Aquinox制药(AQXP)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-01 AccNo: 0001193125-19-209916 Size: 3 MB 网页链接
$Aquinox制药(AQXP)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-05-07 AccNo: 0001193125-19-139021 Size: 2 MB 网页链接
$Aquinox制药(AQXP)$ 10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-04-15 AccNo: 0001193125-19-106596 Size: 316 KB 网页链接
$Aquinox制药(AQXP)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-03-07 AccNo: 0001193125-19-066506 Size: 4 MB 网页链接